ISO/AWI 22442-3

Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents ISO/AWI 22442-3

General information

10.99   New project approved   Oct 29, 2024

ISO

ISO/TC 194 Biological and clinical evaluation of medical devices

International Standard

Scope

ISO 22442-3:2007 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro diagnostic medical devices) utilizing animal tissue or products derived from animal tissue, which are non-viable or have been rendered non-viable. It applies where required by the risk management process as described in ISO 22442-1. It does not cover other transmissible and non-transmissible agents.

Life cycle

PREVIOUSLY

PUBLISHED
ISO 22442-3:2007

NOW

IN_DEVELOPMENT
ISO/AWI 22442-3
10.99 New project approved
Oct 29, 2024




Access Genorma App Everywhere

Get fast and easy access to top European and International standards (EN, ISO, IEC) via your mobile phone, tablet or the web.